Macrogenics Inc. (MGNX) NASDAQ

$5.22 0.13 (2.55%)

Market Cap: $320.81M

As of 08/12/22 04:00 PM EDT. Market closed.

(MGNX)

Macrogenics Inc. (MGNX) NASDAQ

$5.22 0.13 (2.55%)

Market Cap: $320.81M

As of 08/12/22 04:00 PM EDT. Market closed.

MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of ... read more

MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Scott Koenig
Full Time Employees
370
CEO Compensation (Base)
$598,500
CEO Compensation (Total)
$5.21M
URL
Address
9704 Medical Center Dr, Maryland, Rockville, 20850-3343.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Scott Koenig
Full Time Employees
370
CEO Compensation (Base)
$598,500
CEO Compensation (Total)
$5.21M
Address
9704 Medical Center Dr, Maryland, Rockville, 20850-3343.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$5.11
Previous Close
$5.09
Days Range
$5.11 - $5.41
52 week range
$2.13 - $28.09
Volume
1,162,595
Avg. Volume (30 days)
1,022,074
Market Cap
$320.81M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
61,458,790
Open
$5.11
Previous Close
$5.09
Days Range
$5.11 - $5.41
52 week range
$2.13 - $28.09
Volume
1,162,595
Avg. Volume (30 days)
1,022,074
Market Cap
$320.81M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
61,458,790

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MACROGENICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Karrels James SVP, CFO and Secretary Jun 15, 2022 Buy $2.47 40,000 98,800 191,776 Jun 17, 2022, 04:18 PM
Bonvini Ezio Sr VP, Research & CSO May 14, 2022 Option Exercise $4.16 1,666 6,931 114,424 May 17, 2022, 05:28 PM
Koenig Scott President and CEO May 16, 2022 Option Exercise $1.51 53,265 80,430 1,049,636 May 17, 2022, 05:20 PM
Karrels James SVP, CFO and Secretary Mar 28, 2022 Option Exercise $1.51 8,316 12,557 151,776 Mar 28, 2022, 04:56 PM
Risser Eric Blasius Chief Operating Officer Mar 04, 2022 Option Exercise $0.94 500 470 44,968 Mar 04, 2022, 05:45 PM
BIOTECH TARGET N V 10% Owner Nov 19, 2021 Buy $18.50 200,000 3,700,320 7,275,564 Nov 23, 2021, 12:29 PM
Bonvini Ezio Sr VP, Research & CSO Nov 16, 2021 Option Exercise $16.00 2,540 40,640 111,090 Nov 16, 2021, 05:30 PM
BIOTECH TARGET N V 10% Owner Sep 29, 2021 Buy $20.47 100,000 2,047,460 7,075,564 Sep 30, 2021, 03:09 PM
BIOTECH TARGET N V 10% Owner Sep 28, 2021 Buy $20.64 100,000 2,063,960 6,975,564 Sep 30, 2021, 03:09 PM
BIOTECH TARGET N V 10% Owner Sep 17, 2021 Buy $19.93 200,000 3,986,680 6,875,564 Sep 20, 2021, 12:21 PM
BIOTECH TARGET N V 10% Owner Sep 16, 2021 Buy $20.94 400,000 8,376,800 6,675,564 Sep 20, 2021, 12:21 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Jul 16, 2021 Option Exercise $7.51 5,000 37,550 5,000 Jul 20, 2021, 05:09 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Jul 16, 2021 Sale $25.01 5,000 125,050 0 Jul 20, 2021, 05:09 PM
Bonvini Ezio Sr VP, Research & CSO Jun 24, 2021 Option Exercise $16.73 26,076 436,337 108,550 Jun 28, 2021, 08:14 PM
BIOTECH TARGET N V 10% Owner Jun 21, 2021 Buy $21.74 75,000 1,630,170 6,275,564 Jun 23, 2021, 01:33 PM
BIOTECH TARGET N V 10% Owner Jun 16, 2021 Buy $21.04 100,000 2,104,390 6,200,564 Jun 17, 2021, 02:54 PM
BIOTECH TARGET N V 10% Owner Jun 15, 2021 Buy $20.53 75,000 1,539,615 6,100,564 Jun 17, 2021, 02:54 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Apr 15, 2021 Option Exercise $7.51 5,000 37,550 5,000 Apr 19, 2021, 06:37 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Apr 15, 2021 Sale $30.91 5,000 154,550 0 Apr 19, 2021, 06:37 PM
Karrels James SVP, CFO and Secretary Mar 22, 2021 Sale $33.00 15,000 495,000 143,460 Mar 24, 2021, 05:07 PM
Bonvini Ezio Sr VP, Research & CSO Mar 22, 2021 Sale $32.00 3,917 125,344 79,890 Mar 24, 2021, 05:04 PM
Peters Jeffrey Stuart General Counsel Mar 08, 2021 Option Exercise $11.50 21,749 250,114 21,749 Mar 09, 2021, 07:55 PM
Peters Jeffrey Stuart General Counsel Mar 08, 2021 Sale $26.50 21,749 576,349 0 Mar 09, 2021, 07:55 PM
Karrels James SVP, CFO and Secretary Jan 28, 2021 Option Exercise $1.41 6,000 8,490 158,460 Jan 29, 2021, 05:10 PM
Risser Eric Blasius Sr VP & Chief Business Officer Dec 29, 2020 Option Exercise $1.51 500 755 44,968 Dec 30, 2020, 04:05 PM
Risser Eric Blasius Sr VP & Chief Business Officer Dec 29, 2020 Sale $24.10 500 12,050 44,468 Dec 30, 2020, 04:05 PM
Risser Eric Blasius Sr VP & Chief Business Officer Nov 30, 2020 Option Exercise $1.51 500 755 44,968 Dec 01, 2020, 04:15 PM
Risser Eric Blasius Sr VP & Chief Business Officer Nov 30, 2020 Sale $23.35 500 11,675 44,468 Dec 01, 2020, 04:15 PM
Risser Eric Blasius Sr VP & Chief Business Officer Oct 28, 2020 Option Exercise $1.51 1,500 2,265 45,968 Oct 29, 2020, 07:52 PM
Risser Eric Blasius Sr VP & Chief Business Officer Oct 28, 2020 Sale $20.69 1,500 31,035 44,468 Oct 29, 2020, 07:52 PM
Risser Eric Blasius Sr VP & Chief Business Officer Sep 28, 2020 Option Exercise $1.51 500 755 44,968 Sep 29, 2020, 04:44 PM
Risser Eric Blasius Sr VP & Chief Business Officer Sep 28, 2020 Sale $25.33 500 12,665 44,468 Sep 29, 2020, 04:44 PM
Bonvini Ezio Sr VP, Research & CSO Sep 18, 2020 Sale $32.00 18,339 586,848 83,807 Sep 21, 2020, 04:51 PM
Bonvini Ezio Sr VP, Research & CSO Sep 17, 2020 Sale $29.88 44,512 1,330,019 102,146 Sep 21, 2020, 04:51 PM
Galbraith Kenneth Director Sep 09, 2020 Option Exercise $17.38 20,773 361,103 13,849 Sep 10, 2020, 04:44 PM
Galbraith Kenneth Director Sep 09, 2020 Sale $27.11 20,773 563,156 0 Sep 10, 2020, 04:44 PM
Risser Eric Blasius Sr VP & Chief Business Officer Aug 26, 2020 Option Exercise $1.51 500 755 44,968 Aug 27, 2020, 05:04 PM
Risser Eric Blasius Sr VP & Chief Business Officer Aug 26, 2020 Sale $27.10 500 13,550 44,468 Aug 27, 2020, 05:04 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Aug 20, 2020 Option Exercise $7.51 7,500 56,325 7,500 Aug 21, 2020, 04:05 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Aug 20, 2020 Sale $26.87 7,500 201,525 0 Aug 21, 2020, 04:05 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jul 27, 2020 Option Exercise $1.45 4,489 6,500 48,468 Jul 28, 2020, 05:12 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jul 27, 2020 Sale $25.47 4,489 114,319 47,468 Jul 28, 2020, 05:12 PM
Peters Jeffrey Stuart General Counsel Jul 02, 2020 Sale $30.00 202 6,060 0 Jul 06, 2020, 04:25 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jul 02, 2020 Option Exercise $1.51 3,100 4,681 47,568 Jul 06, 2020, 04:25 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jul 02, 2020 Sale $30.00 3,100 93,000 44,468 Jul 06, 2020, 04:25 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jun 24, 2020 Option Exercise $0.94 500 470 44,968 Jun 25, 2020, 04:57 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jun 24, 2020 Sale $28.49 500 14,245 44,468 Jun 25, 2020, 04:57 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 26, 2020 Option Exercise $0.94 500 470 44,968 May 27, 2020, 04:43 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 26, 2020 Sale $26.59 500 13,295 44,468 May 27, 2020, 04:43 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing May 20, 2020 Option Exercise $7.51 7,500 56,325 7,500 May 21, 2020, 07:44 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing May 20, 2020 Sale $25.30 7,500 189,750 0 May 21, 2020, 07:44 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 06, 2020 Option Exercise $1.47 8,032 11,843 52,500 May 07, 2020, 04:22 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 06, 2020 Sale $20.95 8,032 168,300 52,000 May 07, 2020, 04:22 PM
Risser Eric Blasius Sr VP & Chief Business Officer Apr 16, 2020 Option Exercise $0.94 6,000 5,640 44,468 Apr 17, 2020, 04:11 PM
Risser Eric Blasius Sr VP & Chief Business Officer Mar 13, 2020 Option Exercise $0.94 6,000 5,640 38,468 Mar 17, 2020, 04:09 PM
Koenig Scott President and CEO Mar 11, 2020 Option Exercise $0.94 133,163 125,173 943,103 Mar 13, 2020, 04:15 PM
Karrels James SVP, CFO and Secretary Mar 06, 2020 Option Exercise $0.94 4,473 4,205 152,460 Mar 09, 2020, 04:39 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 20, 2020 Option Exercise $0.94 500 470 32,968 Feb 21, 2020, 04:44 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 20, 2020 Sale $10.84 500 5,420 32,468 Feb 21, 2020, 04:44 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 05, 2020 Option Exercise $0.94 623 586 33,091 Feb 06, 2020, 04:41 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 04, 2020 Option Exercise $0.94 30 28 32,498 Feb 06, 2020, 04:41 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 05, 2020 Sale $10.00 623 6,230 32,468 Feb 06, 2020, 04:41 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 04, 2020 Sale $10.00 30 300 32,468 Feb 06, 2020, 04:41 PM
Karrels James SVP, CFO and Secretary Jan 30, 2020 Option Exercise $0.94 12,500 11,750 147,987 Jan 31, 2020, 04:45 PM
Risser Eric Blasius Sr VP & Chief Business Officer Sep 27, 2019 Option Exercise $0.94 1,662 1,562 32,468 Oct 03, 2019, 04:33 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 20, 2019 Option Exercise $0.94 3,000 2,820 33,806 May 22, 2019, 04:21 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 22, 2019 Option Exercise $0.94 1,000 940 31,806 May 22, 2019, 04:21 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 22, 2019 Sale $19.03 1,000 19,026 30,806 May 22, 2019, 04:21 PM
Risser Eric Blasius Sr VP & Chief Business Officer May 20, 2019 Sale $18.38 3,000 55,131 30,806 May 22, 2019, 04:21 PM
Risser Eric Blasius Sr VP & Chief Business Officer Mar 14, 2019 Option Exercise $0.94 2,497 2,347 30,806 Mar 18, 2019, 04:36 PM
Fust Matthew K Director Feb 06, 2019 Option Exercise $20.15 6,924 139,519 7,424 Feb 08, 2019, 05:41 PM
Fust Matthew K Director Feb 06, 2019 Sale $29.38 6,924 203,427 500 Feb 08, 2019, 05:41 PM
Peters Jeffrey Stuart General Counsel Feb 06, 2019 Sale $30.00 68 2,040 202 Feb 08, 2019, 05:40 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Feb 06, 2019 Option Exercise $7.51 1,770 13,293 1,770 Feb 08, 2019, 05:40 PM
Spitznagel Thomas Sr VP, BPD & Manufacturing Feb 06, 2019 Sale $30.00 1,770 53,100 0 Feb 08, 2019, 05:40 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jan 28, 2019 Option Exercise $0.94 6,000 5,640 28,309 Jan 28, 2019, 04:12 PM
Karrels James SVP, CFO and Secretary Jan 24, 2019 Option Exercise $0.94 7,326 6,886 135,487 Jan 28, 2019, 04:10 PM
Karrels James SVP, CFO and Secretary Jan 08, 2019 Option Exercise $0.94 5,314 4,995 128,161 Jan 10, 2019, 03:58 PM
Koenig Scott President and CEO Jan 03, 2019 Option Exercise $0.94 39,897 37,503 213,060 Jan 04, 2019, 04:29 PM
Karrels James SVP, CFO and Secretary Dec 18, 2018 Option Exercise $0.94 5,000 4,700 122,847 Dec 20, 2018, 04:04 PM
Risser Eric Blasius Sr VP & Chief Business Officer Dec 12, 2018 Option Exercise $0.94 5,000 4,700 22,309 Dec 13, 2018, 04:39 PM
Karrels James SVP, CFO and Secretary Nov 27, 2018 Option Exercise $0.94 3,000 2,820 117,847 Nov 27, 2018, 04:44 PM
Risser Eric Blasius Sr VP & Chief Business Officer Nov 13, 2018 Option Exercise $0.94 4,000 3,760 16,100 Nov 14, 2018, 04:48 PM
Koenig Scott President and CEO Nov 13, 2018 Option Exercise $0.94 40,000 37,600 173,163 Nov 14, 2018, 04:32 PM
Risser Eric Blasius Sr VP & Chief Business Officer Oct 22, 2018 Option Exercise $0.94 3,000 2,820 12,100 Oct 23, 2018, 12:32 PM
Risser Eric Blasius Sr VP & Chief Business Officer Mar 12, 2018 Option Exercise $0.94 1,000 940 10,100 Mar 14, 2018, 05:12 PM
Risser Eric Blasius Sr VP & Chief Business Officer Mar 12, 2018 Sale $31.08 1,000 31,080 9,100 Mar 14, 2018, 05:12 PM
Karrels James SVP, CFO and Secretary Mar 05, 2018 Sale $31.00 5,000 155,000 114,847 Mar 07, 2018, 06:46 PM
Risser Eric Blasius Sr VP & Chief Business Officer Mar 02, 2018 Option Exercise $0.94 4,000 3,760 13,100 Mar 06, 2018, 05:24 PM
Risser Eric Blasius Sr VP & Chief Business Officer Mar 02, 2018 Sale $30.00 4,000 120,000 9,100 Mar 06, 2018, 05:24 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 28, 2018 Option Exercise $0.94 1,000 940 10,100 Mar 01, 2018, 05:24 PM
Risser Eric Blasius Sr VP & Chief Business Officer Feb 28, 2018 Sale $25.00 1,000 25,005 9,100 Mar 01, 2018, 05:24 PM
Cilinski Lynn VP, Controller and Treasurer Feb 28, 2018 Option Exercise $1.13 23,967 27,083 25,890 Mar 01, 2018, 05:24 PM
Cilinski Lynn VP, Controller and Treasurer Feb 28, 2018 Sale $25.01 23,967 599,436 1,923 Mar 01, 2018, 05:24 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Feb 26, 2018 Option Exercise $23.46 11,070 259,702 18,930 Feb 27, 2018, 05:49 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jan 24, 2018 Option Exercise $0.94 3,000 2,820 12,100 Jan 26, 2018, 04:01 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jan 24, 2018 Sale $22.50 3,000 67,500 9,100 Jan 26, 2018, 04:01 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jan 24, 2018 Option Exercise $0.94 3,000 2,820 12,100 Jan 25, 2018, 05:22 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jan 24, 2018 Sale $22.50 3,000 67,500 9,100 Jan 25, 2018, 05:22 PM
Karrels James SVP, CFO and Secretary Jan 16, 2018 Option Exercise $0.94 6,516 6,125 119,847 Jan 18, 2018, 05:19 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Jan 17, 2018 Option Exercise $4.70 2,524 11,863 32,524 Jan 18, 2018, 05:19 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Jan 16, 2018 Option Exercise $4.70 2,476 11,637 32,476 Jan 18, 2018, 05:19 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Jan 17, 2018 Sale $20.00 2,524 50,480 30,000 Jan 18, 2018, 05:19 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Jan 16, 2018 Sale $20.00 2,476 49,520 30,000 Jan 18, 2018, 05:19 PM
Risser Eric Blasius Sr VP & Chief Business Officer Jan 17, 2018 Option Exercise $0.94 2,000 1,880 9,100 Jan 18, 2018, 05:19 PM
Karrels James SVP, CFO and Secretary Dec 29, 2017 Option Exercise $0.94 3,000 2,820 113,331 Jan 03, 2018, 12:00 AM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Nov 21, 2017 Option Exercise $4.70 5,000 23,500 35,000 Nov 21, 2017, 05:15 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Nov 21, 2017 Sale $20.00 5,000 100,000 30,000 Nov 21, 2017, 05:15 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Oct 25, 2017 Option Exercise $4.70 10,000 47,000 40,000 Oct 26, 2017, 09:37 AM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Oct 25, 2017 Sale $20.00 10,000 200,000 30,000 Oct 26, 2017, 09:37 AM
Karrels James SVP, CFO and Secretary Sep 05, 2017 Option Exercise $0.94 5,000 4,700 110,331 Sep 07, 2017, 04:54 PM
Risser Eric Blasius Sr VP & Chief Business Officer Sep 05, 2017 Option Exercise $0.94 2,000 1,880 6,000 Sep 07, 2017, 04:52 PM
Bonvini Ezio Sr VP, Research & CSO Jul 26, 2017 Option Exercise $1.22 53,264 65,248 146,658 Jul 27, 2017, 04:47 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Jun 05, 2017 Option Exercise $4.70 5,000 23,500 35,000 Jun 06, 2017, 04:04 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Jun 05, 2017 Sale $20.00 5,000 100,000 30,000 Jun 06, 2017, 04:04 PM
SARAN ATUL SVP & General Counsel Apr 28, 2017 Option Exercise $21.61 1,862 40,238 16,986 May 02, 2017, 12:58 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Apr 19, 2017 Option Exercise $4.70 15,000 70,500 45,000 Apr 20, 2017, 04:15 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Apr 19, 2017 Sale $20.00 15,000 300,000 30,000 Apr 20, 2017, 04:15 PM
Karrels James SVP, CFO and Secretary Jan 25, 2017 Option Exercise $0.94 5,000 4,700 105,331 Jan 26, 2017, 04:36 PM
Koenig Scott President and CEO Jan 17, 2017 Option Exercise $0.94 79,898 75,104 133,163 Jan 19, 2017, 04:40 PM
Bonvini Ezio Sr VP, Research & CSO Feb 11, 2016 Option Exercise $0.94 11,962 11,244 95,595 Oct 21, 2016, 07:19 PM
Bonvini Ezio Sr VP, Research & CSO Oct 19, 2016 Option Exercise $0.94 5,349 5,028 100,944 Oct 21, 2016, 07:19 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Oct 03, 2016 Option Exercise $4.70 10,000 47,000 10,000 Oct 19, 2016, 05:20 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Oct 03, 2016 Sale $29.34 10,000 293,400 0 Oct 19, 2016, 05:20 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Oct 03, 2016 Option Exercise $4.70 10,000 47,000 10,000 Oct 05, 2016, 04:49 PM
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Oct 03, 2016 Sale $29.34 10,000 293,400 0 Oct 05, 2016, 04:49 PM
Cilinski Lynn VP, Controller and Treasurer Oct 03, 2016 Option Exercise $0.94 6,231 5,857 8,154 Oct 05, 2016, 04:49 PM
Cilinski Lynn VP, Controller and Treasurer Oct 03, 2016 Sale $29.28 6,231 182,444 1,923 Oct 05, 2016, 04:49 PM
Wigginton Jon Marc Sr VP Clinical Dev & CMO Aug 01, 2016 Option Exercise $4.70 20,000 94,000 20,000 Aug 03, 2016, 04:51 PM
Wigginton Jon Marc Sr VP Clinical Dev & CMO Aug 01, 2016 Sale $30.78 20,000 615,600 0 Aug 03, 2016, 04:51 PM
Wigginton Jon Marc Sr VP Clinical Dev & CMO Jul 01, 2016 Option Exercise $4.70 5,000 23,500 5,000 Jul 06, 2016, 08:44 PM
Wigginton Jon Marc Sr VP Clinical Dev & CMO Jul 01, 2016 Sale $27.22 5,000 136,100 0 Jul 06, 2016, 08:44 PM
Cilinski Lynn VP, Controller and Treasurer Jul 01, 2016 Option Exercise $0.94 8,922 8,387 10,845 Jul 06, 2016, 08:43 PM
Cilinski Lynn VP, Controller and Treasurer Jul 01, 2016 Sale $27.22 8,922 242,857 1,923 Jul 06, 2016, 08:43 PM
SARAN ATUL SVP & General Counsel Apr 28, 2016 Option Exercise $20.84 1,862 38,804 18,848 Jun 01, 2016, 11:01 AM
Cilinski Lynn VP, Controller and Treasurer May 27, 2016 Option Exercise $0.94 5,000 4,700 6,923 May 27, 2016, 02:32 PM
Cilinski Lynn VP, Controller and Treasurer May 27, 2016 Sale $25.00 5,000 125,000 1,923 May 27, 2016, 02:32 PM
Koenig Scott President and CEO May 16, 2016 Option Exercise $0.94 34,619 32,542 167,782 May 17, 2016, 11:55 AM
Koenig Scott President and CEO May 11, 2016 Option Exercise $0.94 79,898 75,104 133,163 May 13, 2016, 10:25 AM
SARAN ATUL SVP & General Counsel Apr 28, 2016 Option Exercise $20.84 1,730 36,053 18,980 Apr 29, 2016, 03:38 PM
Costa Paulo F Director Mar 03, 2016 Buy $17.20 10,000 172,000 59,435 Mar 04, 2016, 08:12 AM
Risser Eric Blasius SVP, Business Development Feb 08, 2016 Option Exercise $0.94 2,500 2,350 4,000 Feb 10, 2016, 08:51 PM
Karrels James SVP, CFO and Secretary Jan 29, 2016 Option Exercise $0.94 10,000 9,400 100,331 Feb 02, 2016, 04:42 PM
Stein Kathryn E SVP, Product Dev. & Regulatory Jan 07, 2016 Option Exercise $0.86 52,350 44,825 95,555 Jan 11, 2016, 01:39 PM
Bonvini Ezio Senior VP, Research Jan 07, 2016 Option Exercise $0.94 13,316 12,517 83,633 Jan 11, 2016, 01:39 PM
Wigginton Jon Marc Sr VP, Clinical Jan 04, 2016 Option Exercise $4.70 10,000 47,000 10,000 Jan 06, 2016, 06:51 PM
Wigginton Jon Marc Sr VP, Clinical Jan 04, 2016 Sale $29.64 10,000 296,400 0 Jan 06, 2016, 06:51 PM
Risser Eric Blasius SVP, Business Development Dec 23, 2015 Option Exercise $0.94 1,500 1,410 1,500 Dec 23, 2015, 01:26 PM
Cilinski Lynn VP, Controller and Treasurer Jul 01, 2015 Option Exercise $0.94 3,815 3,586 7,659 Nov 24, 2015, 03:32 PM
Cilinski Lynn VP, Controller and Treasurer Nov 23, 2015 Option Exercise $0.94 1,185 1,114 5,029 Nov 24, 2015, 03:32 PM
Cilinski Lynn VP, Controller and Treasurer Nov 23, 2015 Sale $35.00 6,921 242,235 3,844 Nov 24, 2015, 03:32 PM
Bonvini Ezio Senior VP, Research Nov 16, 2015 Sale $31.44 3,117 97,998 70,317 Nov 17, 2015, 03:22 PM
Bonvini Ezio Senior VP, Research Oct 15, 2015 Sale $25.21 6,233 157,134 73,434 Oct 19, 2015, 03:01 PM
Bonvini Ezio Senior VP, Research Oct 13, 2015 Option Exercise $13.12 29,042 381,031 94,188 Oct 15, 2015, 02:37 PM
Karrels James SVP, CFO and Secretary Oct 07, 2015 Option Exercise $0.94 6,000 5,640 10,100 Oct 09, 2015, 09:52 AM
Wigginton Jon Marc Sr VP, Clinical Oct 01, 2015 Option Exercise $4.70 5,000 23,500 5,000 Oct 07, 2015, 04:08 PM
Wigginton Jon Marc Sr VP, Clinical Oct 01, 2015 Sale $21.11 5,000 105,550 0 Oct 07, 2015, 04:08 PM
Wigginton Jon Marc Sr VP, Clinical Aug 03, 2015 Option Exercise $4.70 10,000 47,000 10,000 Oct 07, 2015, 04:07 PM
Wigginton Jon Marc Sr VP, Clinical Aug 03, 2015 Sale $37.15 10,000 371,500 0 Oct 07, 2015, 04:07 PM
Bonvini Ezio Senior VP, Research Oct 02, 2015 Option Exercise $0.94 17,877 16,804 79,667 Oct 06, 2015, 02:19 PM
Wigginton Jon Marc Sr VP, Clinical Oct 01, 2015 Option Exercise $4.70 5,000 23,500 5,000 Oct 02, 2015, 04:22 PM
Wigginton Jon Marc Sr VP, Clinical Oct 01, 2015 Sale $21.11 5,000 105,550 0 Oct 02, 2015, 04:22 PM
Bonvini Ezio Senior VP, Research Sep 18, 2015 Option Exercise $0.94 7,000 6,580 61,790 Sep 22, 2015, 03:19 PM
Bonvini Ezio Senior VP, Research Sep 16, 2015 Option Exercise $0.94 4,000 3,760 54,790 Sep 18, 2015, 10:33 AM
Bonvini Ezio Senior VP, Research Aug 26, 2015 Option Exercise $0.94 5,000 4,700 45,790 Aug 28, 2015, 11:30 AM
Bonvini Ezio Senior VP, Research Aug 27, 2015 Option Exercise $0.94 5,000 4,700 50,790 Aug 28, 2015, 11:30 AM
Bonvini Ezio Senior VP, Research Aug 10, 2015 Option Exercise $0.94 80,000 75,200 40,790 Aug 11, 2015, 08:41 AM
Wigginton Jon Marc Sr VP, Clinical Aug 03, 2015 Option Exercise $4.70 10,000 47,000 10,000 Aug 03, 2015, 02:47 PM
Wigginton Jon Marc Sr VP, Clinical Aug 03, 2015 Sale $37.15 10,000 371,500 0 Aug 03, 2015, 02:47 PM
Bonvini Ezio Senior VP, Research Jul 10, 2015 Option Exercise $0.71 2,400 1,704 39,190 Jul 13, 2015, 03:23 PM
Bonvini Ezio Senior VP, Research Jul 10, 2015 Sale $38.09 2,400 91,416 36,790 Jul 13, 2015, 03:23 PM
Cilinski Lynn VP, Controller and Treasurer Jul 01, 2015 Option Exercise $0.94 5,000 4,700 10,765 Jul 01, 2015, 04:28 PM
Cilinski Lynn VP, Controller and Treasurer Jul 01, 2015 Sale $37.15 6,921 257,115 5,765 Jul 01, 2015, 04:28 PM
Wigginton Jon Marc Sr VP, Clinical Jul 01, 2015 Option Exercise $4.70 5,000 23,500 5,000 Jul 01, 2015, 04:28 PM
Wigginton Jon Marc Sr VP, Clinical Jul 01, 2015 Sale $37.15 5,000 185,750 0 Jul 01, 2015, 04:28 PM
Bonvini Ezio Senior VP, Research Jun 30, 2015 Option Exercise $0.71 6,497 4,613 43,287 Jul 01, 2015, 04:27 PM
Bonvini Ezio Senior VP, Research Jun 30, 2015 Sale $38.07 6,497 247,341 36,790 Jul 01, 2015, 04:27 PM
Bonvini Ezio Senior VP, Research Jun 24, 2015 Option Exercise $0.71 6,097 4,329 42,887 Jul 01, 2015, 04:27 PM
Bonvini Ezio Senior VP, Research Jun 24, 2015 Sale $38.08 6,097 232,174 36,790 Jul 01, 2015, 04:27 PM
Bonvini Ezio Senior VP, Research Jun 23, 2015 Option Exercise $0.71 13,054 9,268 49,844 Jul 01, 2015, 04:27 PM
Bonvini Ezio Senior VP, Research Jun 23, 2015 Sale $38.14 13,054 497,880 36,790 Jul 01, 2015, 04:27 PM
Bonvini Ezio Senior VP, Research Jun 24, 2015 Sale $38.08 6,097 232,174 17,639 Jun 25, 2015, 03:39 PM
Bonvini Ezio Senior VP, Research Jun 23, 2015 Sale $38.14 13,054 497,880 23,736 Jun 24, 2015, 03:07 PM
Cilinski Lynn VP, Controller and Treasurer Jun 15, 2015 Option Exercise $0.94 5,000 4,700 16,465 Jun 16, 2015, 01:28 PM
Cilinski Lynn VP, Controller and Treasurer Jun 15, 2015 Sale $35.00 10,700 374,500 11,465 Jun 16, 2015, 01:28 PM
Bonvini Ezio Senior VP, Research Jun 15, 2015 Option Exercise $0.71 6,233 4,425 43,023 Jun 16, 2015, 01:28 PM
Bonvini Ezio Senior VP, Research Jun 15, 2015 Sale $34.01 6,233 211,984 36,790 Jun 16, 2015, 01:28 PM
Bonvini Ezio Senior VP, Research May 15, 2015 Option Exercise $0.71 6,233 4,425 43,023 May 18, 2015, 04:15 PM
Bonvini Ezio Senior VP, Research May 15, 2015 Sale $30.24 6,233 188,486 36,790 May 18, 2015, 04:15 PM
SARAN ATUL General Counsel Apr 28, 2015 Option Exercise $32.02 925 29,619 20,710 Apr 29, 2015, 02:32 PM
Bonvini Ezio Senior VP, Research Apr 15, 2015 Option Exercise $0.71 6,233 4,425 43,023 Apr 16, 2015, 11:12 AM
Bonvini Ezio Senior VP, Research Apr 15, 2015 Sale $33.98 6,233 211,797 36,790 Apr 16, 2015, 11:12 AM
Wigginton Jon Marc Sr VP, Clinical Apr 01, 2014 Option Exercise $4.70 5,000 23,500 5,000 Apr 03, 2015, 07:57 AM
Wigginton Jon Marc Sr VP, Clinical Apr 01, 2015 Sale $30.86 5,000 154,300 0 Apr 03, 2015, 07:57 AM
Wigginton Jon Marc Sr VP, Clinical Feb 02, 2015 Option Exercise $4.70 5,000 23,500 5,000 Feb 03, 2015, 02:58 PM
Wigginton Jon Marc Sr VP, Clinical Feb 02, 2015 Sale $31.04 5,000 155,200 0 Feb 03, 2015, 02:58 PM
Karrels James VP, CFO and Secretary Dec 24, 2014 Option Exercise $0.94 4,100 3,854 4,100 Dec 29, 2014, 08:05 AM
Stein Kathryn E SVP, Product Dev. & Regulatory Dec 22, 2014 Option Exercise $0.07 10,946 777 54,151 Dec 23, 2014, 11:55 AM
Stein Kathryn E SVP, Product Dev. & Regulatory Dec 22, 2014 Sale $37.00 10,946 405,002 43,205 Dec 23, 2014, 11:55 AM
Risser Eric Blasius VP, Business Development Dec 22, 2014 Option Exercise $19.59 10,000 195,950 5,000 Dec 23, 2014, 11:33 AM
Risser Eric Blasius VP, Business Development Dec 18, 2014 Option Exercise $0.94 10,000 9,400 10,000 Dec 22, 2014, 11:04 AM
Risser Eric Blasius VP, Business Development Dec 18, 2014 Sale $33.50 10,000 335,000 0 Dec 22, 2014, 11:04 AM
Stein Kathryn E SVP, Product Dev. & Regulatory Dec 18, 2014 Option Exercise $0.71 10,946 7,772 54,151 Dec 22, 2014, 11:02 AM
Stein Kathryn E SVP, Product Dev. & Regulatory Dec 18, 2014 Sale $33.00 10,946 361,218 43,205 Dec 22, 2014, 11:02 AM
Koenig Scott President and CEO Dec 19, 2014 Option Exercise $0.94 62,205 58,473 703,414 Dec 22, 2014, 11:02 AM
Risser Eric Blasius VP, Business Development Nov 24, 2014 Option Exercise $0.94 10,000 9,400 10,000 Nov 25, 2014, 02:12 PM
Risser Eric Blasius VP, Business Development Nov 24, 2014 Sale $27.75 10,000 277,500 0 Nov 25, 2014, 02:12 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff Nov 21, 2014 Option Exercise $0.71 10,946 7,772 54,151 Nov 24, 2014, 04:34 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff Nov 21, 2014 Sale $27.00 10,946 295,542 43,205 Nov 24, 2014, 04:34 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff Nov 17, 2014 Option Exercise $0.94 2,090 1,965 45,295 Nov 17, 2014, 05:11 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff Nov 14, 2014 Option Exercise $0.94 23,211 21,818 66,416 Nov 17, 2014, 05:11 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff Nov 14, 2014 Sale $23.33 23,211 541,513 43,205 Nov 17, 2014, 05:11 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff Nov 17, 2014 Sale $22.95 2,090 47,966 43,205 Nov 17, 2014, 05:11 PM
Bonvini Ezio Senior VP, Research Nov 14, 2014 Option Exercise $0.71 3,900 2,769 36,390 Nov 17, 2014, 05:11 PM
Risser Eric Blasius VP, Business Development Nov 13, 2014 Option Exercise $0.94 10,000 9,400 10,000 Nov 13, 2014, 02:48 PM
Risser Eric Blasius VP, Business Development Nov 12, 2014 Option Exercise $0.94 10,000 9,400 15,000 Nov 13, 2014, 02:48 PM
Risser Eric Blasius VP, Business Development Nov 12, 2014 Sale $23.00 15,000 345,000 0 Nov 13, 2014, 02:48 PM
Risser Eric Blasius VP, Business Development Nov 13, 2014 Sale $25.00 10,000 250,000 0 Nov 13, 2014, 02:48 PM
SARAN ATUL See remarks Oct 28, 2014 Option Exercise $21.79 865 18,848 21,635 Oct 30, 2014, 04:51 PM
Bonvini Ezio Senior VP, Research Oct 10, 2014 Option Exercise $0.71 400 284 32,890 Oct 15, 2014, 01:38 PM
Bonvini Ezio Senior VP, Research Oct 08, 2014 Option Exercise $0.94 1,597 1,501 29,827 Oct 10, 2014, 02:54 PM
Bonvini Ezio Senior VP, Research Oct 09, 2014 Option Exercise $0.71 2,663 1,891 32,490 Oct 10, 2014, 02:54 PM
Wigginton Jon Marc Sr V.P., Clinical Oct 01, 2014 Option Exercise $4.70 5,000 23,500 5,000 Oct 02, 2014, 11:33 AM
Wigginton Jon Marc Sr V.P., Clinical Oct 01, 2014 Sale $20.48 5,000 102,400 0 Oct 02, 2014, 11:33 AM
Risser Eric Blasius VP, Business Development Sep 02, 2014 Sale $20.89 8,316 173,721 5,000 Sep 02, 2014, 04:33 PM
Wigginton Jon Marc Senior VP, Clinical Dev. Aug 18, 2014 Option Exercise $4.70 5,000 23,500 5,000 Aug 19, 2014, 06:43 PM
Wigginton Jon Marc Senior VP, Clinical Dev. Aug 18, 2014 Sale $20.52 5,000 102,600 0 Aug 19, 2014, 06:43 PM
Risser Eric Blasius VP, Business Development Jun 30, 2014 Option Exercise $0.94 8,000 7,520 21,316 Jul 01, 2014, 07:04 PM
Risser Eric Blasius VP, Business Development Jun 30, 2014 Sale $21.84 8,000 174,720 13,316 Jul 01, 2014, 07:04 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff May 29, 2014 Option Exercise $0.71 10,946 7,772 54,151 May 30, 2014, 02:01 PM
Stein Kathryn E Senior VP, Prd Dev & Reg Aff May 29, 2014 Sale $19.75 10,946 216,184 43,205 May 30, 2014, 02:01 PM
HURWITZ EDWARD Director Feb 18, 2014 Sale $36.50 308,513 11,260,725 1,704,996 Feb 18, 2014, 04:16 PM
ORONSKY ARNOLD L Director Feb 18, 2014 Sale $36.50 200,000 7,300,000 1,708,716 Feb 18, 2014, 04:03 PM
Galbraith Kenneth Director Oct 16, 2013 Buy $16.00 46,875 750,000 46,875 Oct 18, 2013, 02:36 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Karrels James SVP, CFO and Secretary 06/15/2022 98,800
Bonvini Ezio Sr VP, Research & CSO 05/14/2022 6,931
Koenig Scott President and CEO 05/16/2022 80,430
Karrels James SVP, CFO and Secretary 03/28/2022 12,557
Risser Eric Blasius Chief Operating Officer 03/04/2022 470
BIOTECH TARGET N V 10% Owner 11/19/2021 3,700,320
Bonvini Ezio Sr VP, Research & CSO 11/16/2021 40,640
BIOTECH TARGET N V 10% Owner 09/29/2021 2,047,460
BIOTECH TARGET N V 10% Owner 09/28/2021 2,063,960
BIOTECH TARGET N V 10% Owner 09/17/2021 3,986,680
BIOTECH TARGET N V 10% Owner 09/16/2021 8,376,800
Spitznagel Thomas Sr VP, BPD & Manufacturing 07/16/2021 37,550
Spitznagel Thomas Sr VP, BPD & Manufacturing 07/16/2021 125,050
Bonvini Ezio Sr VP, Research & CSO 06/24/2021 436,337
BIOTECH TARGET N V 10% Owner 06/21/2021 1,630,170
BIOTECH TARGET N V 10% Owner 06/16/2021 2,104,390
BIOTECH TARGET N V 10% Owner 06/15/2021 1,539,615
Spitznagel Thomas Sr VP, BPD & Manufacturing 04/15/2021 37,550
Spitznagel Thomas Sr VP, BPD & Manufacturing 04/15/2021 154,550
Karrels James SVP, CFO and Secretary 03/22/2021 495,000
Bonvini Ezio Sr VP, Research & CSO 03/22/2021 125,344
Peters Jeffrey Stuart General Counsel 03/08/2021 250,114
Peters Jeffrey Stuart General Counsel 03/08/2021 576,349
Karrels James SVP, CFO and Secretary 01/28/2021 8,490
Risser Eric Blasius Sr VP & Chief Business Officer 12/29/2020 755
Risser Eric Blasius Sr VP & Chief Business Officer 12/29/2020 12,050
Risser Eric Blasius Sr VP & Chief Business Officer 11/30/2020 755
Risser Eric Blasius Sr VP & Chief Business Officer 11/30/2020 11,675
Risser Eric Blasius Sr VP & Chief Business Officer 10/28/2020 2,265
Risser Eric Blasius Sr VP & Chief Business Officer 10/28/2020 31,035
Risser Eric Blasius Sr VP & Chief Business Officer 09/28/2020 755
Risser Eric Blasius Sr VP & Chief Business Officer 09/28/2020 12,665
Bonvini Ezio Sr VP, Research & CSO 09/18/2020 586,848
Bonvini Ezio Sr VP, Research & CSO 09/17/2020 1,330,019
Galbraith Kenneth Director 09/09/2020 361,103
Galbraith Kenneth Director 09/09/2020 563,156
Risser Eric Blasius Sr VP & Chief Business Officer 08/26/2020 755
Risser Eric Blasius Sr VP & Chief Business Officer 08/26/2020 13,550
Spitznagel Thomas Sr VP, BPD & Manufacturing 08/20/2020 56,325
Spitznagel Thomas Sr VP, BPD & Manufacturing 08/20/2020 201,525
Risser Eric Blasius Sr VP & Chief Business Officer 07/27/2020 6,500
Risser Eric Blasius Sr VP & Chief Business Officer 07/27/2020 114,319
Peters Jeffrey Stuart General Counsel 07/02/2020 6,060
Risser Eric Blasius Sr VP & Chief Business Officer 07/02/2020 4,681
Risser Eric Blasius Sr VP & Chief Business Officer 07/02/2020 93,000
Risser Eric Blasius Sr VP & Chief Business Officer 06/24/2020 470
Risser Eric Blasius Sr VP & Chief Business Officer 06/24/2020 14,245
Risser Eric Blasius Sr VP & Chief Business Officer 05/26/2020 470
Risser Eric Blasius Sr VP & Chief Business Officer 05/26/2020 13,295
Spitznagel Thomas Sr VP, BPD & Manufacturing 05/20/2020 56,325
Spitznagel Thomas Sr VP, BPD & Manufacturing 05/20/2020 189,750
Risser Eric Blasius Sr VP & Chief Business Officer 05/06/2020 11,843
Risser Eric Blasius Sr VP & Chief Business Officer 05/06/2020 168,300
Risser Eric Blasius Sr VP & Chief Business Officer 04/16/2020 5,640
Risser Eric Blasius Sr VP & Chief Business Officer 03/13/2020 5,640
Koenig Scott President and CEO 03/11/2020 125,173
Karrels James SVP, CFO and Secretary 03/06/2020 4,205
Risser Eric Blasius Sr VP & Chief Business Officer 02/20/2020 470
Risser Eric Blasius Sr VP & Chief Business Officer 02/20/2020 5,420
Risser Eric Blasius Sr VP & Chief Business Officer 02/05/2020 586
Risser Eric Blasius Sr VP & Chief Business Officer 02/04/2020 28
Risser Eric Blasius Sr VP & Chief Business Officer 02/05/2020 6,230
Risser Eric Blasius Sr VP & Chief Business Officer 02/04/2020 300
Karrels James SVP, CFO and Secretary 01/30/2020 11,750
Risser Eric Blasius Sr VP & Chief Business Officer 09/27/2019 1,562
Risser Eric Blasius Sr VP & Chief Business Officer 05/20/2019 2,820
Risser Eric Blasius Sr VP & Chief Business Officer 05/22/2019 940
Risser Eric Blasius Sr VP & Chief Business Officer 05/22/2019 19,026
Risser Eric Blasius Sr VP & Chief Business Officer 05/20/2019 55,131
Risser Eric Blasius Sr VP & Chief Business Officer 03/14/2019 2,347
Fust Matthew K Director 02/06/2019 139,519
Fust Matthew K Director 02/06/2019 203,427
Peters Jeffrey Stuart General Counsel 02/06/2019 2,040
Spitznagel Thomas Sr VP, BPD & Manufacturing 02/06/2019 13,293
Spitznagel Thomas Sr VP, BPD & Manufacturing 02/06/2019 53,100
Risser Eric Blasius Sr VP & Chief Business Officer 01/28/2019 5,640
Karrels James SVP, CFO and Secretary 01/24/2019 6,886
Karrels James SVP, CFO and Secretary 01/08/2019 4,995
Koenig Scott President and CEO 01/03/2019 37,503
Karrels James SVP, CFO and Secretary 12/18/2018 4,700
Risser Eric Blasius Sr VP & Chief Business Officer 12/12/2018 4,700
Karrels James SVP, CFO and Secretary 11/27/2018 2,820
Risser Eric Blasius Sr VP & Chief Business Officer 11/13/2018 3,760
Koenig Scott President and CEO 11/13/2018 37,600
Risser Eric Blasius Sr VP & Chief Business Officer 10/22/2018 2,820
Risser Eric Blasius Sr VP & Chief Business Officer 03/12/2018 940
Risser Eric Blasius Sr VP & Chief Business Officer 03/12/2018 31,080
Karrels James SVP, CFO and Secretary 03/05/2018 155,000
Risser Eric Blasius Sr VP & Chief Business Officer 03/02/2018 3,760
Risser Eric Blasius Sr VP & Chief Business Officer 03/02/2018 120,000
Risser Eric Blasius Sr VP & Chief Business Officer 02/28/2018 940
Risser Eric Blasius Sr VP & Chief Business Officer 02/28/2018 25,005
Cilinski Lynn VP, Controller and Treasurer 02/28/2018 27,083
Cilinski Lynn VP, Controller and Treasurer 02/28/2018 599,436
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 02/26/2018 259,702
Risser Eric Blasius Sr VP & Chief Business Officer 01/24/2018 2,820
Risser Eric Blasius Sr VP & Chief Business Officer 01/24/2018 67,500
Risser Eric Blasius Sr VP & Chief Business Officer 01/24/2018 2,820
Risser Eric Blasius Sr VP & Chief Business Officer 01/24/2018 67,500
Karrels James SVP, CFO and Secretary 01/16/2018 6,125
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 01/17/2018 11,863
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 01/16/2018 11,637
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 01/17/2018 50,480
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 01/16/2018 49,520
Risser Eric Blasius Sr VP & Chief Business Officer 01/17/2018 1,880
Karrels James SVP, CFO and Secretary 12/29/2017 2,820
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 11/21/2017 23,500
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 11/21/2017 100,000
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 10/25/2017 47,000
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 10/25/2017 200,000
Karrels James SVP, CFO and Secretary 09/05/2017 4,700
Risser Eric Blasius Sr VP & Chief Business Officer 09/05/2017 1,880
Bonvini Ezio Sr VP, Research & CSO 07/26/2017 65,248
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 06/05/2017 23,500
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 06/05/2017 100,000
SARAN ATUL SVP & General Counsel 04/28/2017 40,238
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 04/19/2017 70,500
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 04/19/2017 300,000
Karrels James SVP, CFO and Secretary 01/25/2017 4,700
Koenig Scott President and CEO 01/17/2017 75,104
Bonvini Ezio Sr VP, Research & CSO 02/11/2016 11,244
Bonvini Ezio Sr VP, Research & CSO 10/19/2016 5,028
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 10/03/2016 47,000
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 10/03/2016 293,400
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 10/03/2016 47,000
Wigginton Jon Marc Sr VP, Clinical Dev. & CMO 10/03/2016 293,400
Cilinski Lynn VP, Controller and Treasurer 10/03/2016 5,857
Cilinski Lynn VP, Controller and Treasurer 10/03/2016 182,444
Wigginton Jon Marc Sr VP Clinical Dev & CMO 08/01/2016 94,000
Wigginton Jon Marc Sr VP Clinical Dev & CMO 08/01/2016 615,600
Wigginton Jon Marc Sr VP Clinical Dev & CMO 07/01/2016 23,500
Wigginton Jon Marc Sr VP Clinical Dev & CMO 07/01/2016 136,100
Cilinski Lynn VP, Controller and Treasurer 07/01/2016 8,387
Cilinski Lynn VP, Controller and Treasurer 07/01/2016 242,857
SARAN ATUL SVP & General Counsel 04/28/2016 38,804
Cilinski Lynn VP, Controller and Treasurer 05/27/2016 4,700
Cilinski Lynn VP, Controller and Treasurer 05/27/2016 125,000
Koenig Scott President and CEO 05/16/2016 32,542
Koenig Scott President and CEO 05/11/2016 75,104
SARAN ATUL SVP & General Counsel 04/28/2016 36,053
Costa Paulo F Director 03/03/2016 172,000
Risser Eric Blasius SVP, Business Development 02/08/2016 2,350
Karrels James SVP, CFO and Secretary 01/29/2016 9,400
Stein Kathryn E SVP, Product Dev. & Regulatory 01/07/2016 44,825
Bonvini Ezio Senior VP, Research 01/07/2016 12,517
Wigginton Jon Marc Sr VP, Clinical 01/04/2016 47,000
Wigginton Jon Marc Sr VP, Clinical 01/04/2016 296,400
Risser Eric Blasius SVP, Business Development 12/23/2015 1,410
Cilinski Lynn VP, Controller and Treasurer 07/01/2015 3,586
Cilinski Lynn VP, Controller and Treasurer 11/23/2015 1,114
Cilinski Lynn VP, Controller and Treasurer 11/23/2015 242,235
Bonvini Ezio Senior VP, Research 11/16/2015 97,998
Bonvini Ezio Senior VP, Research 10/15/2015 157,134
Bonvini Ezio Senior VP, Research 10/13/2015 381,031
Karrels James SVP, CFO and Secretary 10/07/2015 5,640
Wigginton Jon Marc Sr VP, Clinical 10/01/2015 23,500
Wigginton Jon Marc Sr VP, Clinical 10/01/2015 105,550
Wigginton Jon Marc Sr VP, Clinical 08/03/2015 47,000
Wigginton Jon Marc Sr VP, Clinical 08/03/2015 371,500
Bonvini Ezio Senior VP, Research 10/02/2015 16,804
Wigginton Jon Marc Sr VP, Clinical 10/01/2015 23,500
Wigginton Jon Marc Sr VP, Clinical 10/01/2015 105,550
Bonvini Ezio Senior VP, Research 09/18/2015 6,580
Bonvini Ezio Senior VP, Research 09/16/2015 3,760
Bonvini Ezio Senior VP, Research 08/26/2015 4,700
Bonvini Ezio Senior VP, Research 08/27/2015 4,700
Bonvini Ezio Senior VP, Research 08/10/2015 75,200
Wigginton Jon Marc Sr VP, Clinical 08/03/2015 47,000
Wigginton Jon Marc Sr VP, Clinical 08/03/2015 371,500
Bonvini Ezio Senior VP, Research 07/10/2015 1,704
Bonvini Ezio Senior VP, Research 07/10/2015 91,416
Cilinski Lynn VP, Controller and Treasurer 07/01/2015 4,700
Cilinski Lynn VP, Controller and Treasurer 07/01/2015 257,115
Wigginton Jon Marc Sr VP, Clinical 07/01/2015 23,500
Wigginton Jon Marc Sr VP, Clinical 07/01/2015 185,750
Bonvini Ezio Senior VP, Research 06/30/2015 4,613
Bonvini Ezio Senior VP, Research 06/30/2015 247,341
Bonvini Ezio Senior VP, Research 06/24/2015 4,329
Bonvini Ezio Senior VP, Research 06/24/2015 232,174
Bonvini Ezio Senior VP, Research 06/23/2015 9,268
Bonvini Ezio Senior VP, Research 06/23/2015 497,880
Bonvini Ezio Senior VP, Research 06/24/2015 232,174
Bonvini Ezio Senior VP, Research 06/23/2015 497,880
Cilinski Lynn VP, Controller and Treasurer 06/15/2015 4,700
Cilinski Lynn VP, Controller and Treasurer 06/15/2015 374,500
Bonvini Ezio Senior VP, Research 06/15/2015 4,425
Bonvini Ezio Senior VP, Research 06/15/2015 211,984
Bonvini Ezio Senior VP, Research 05/15/2015 4,425
Bonvini Ezio Senior VP, Research 05/15/2015 188,486
SARAN ATUL General Counsel 04/28/2015 29,619
Bonvini Ezio Senior VP, Research 04/15/2015 4,425
Bonvini Ezio Senior VP, Research 04/15/2015 211,797
Wigginton Jon Marc Sr VP, Clinical 04/01/2014 23,500
Wigginton Jon Marc Sr VP, Clinical 04/01/2015 154,300
Wigginton Jon Marc Sr VP, Clinical 02/02/2015 23,500
Wigginton Jon Marc Sr VP, Clinical 02/02/2015 155,200
Karrels James VP, CFO and Secretary 12/24/2014 3,854
Stein Kathryn E SVP, Product Dev. & Regulatory 12/22/2014 777
Stein Kathryn E SVP, Product Dev. & Regulatory 12/22/2014 405,002
Risser Eric Blasius VP, Business Development 12/22/2014 195,950
Risser Eric Blasius VP, Business Development 12/18/2014 9,400
Risser Eric Blasius VP, Business Development 12/18/2014 335,000
Stein Kathryn E SVP, Product Dev. & Regulatory 12/18/2014 7,772
Stein Kathryn E SVP, Product Dev. & Regulatory 12/18/2014 361,218
Koenig Scott President and CEO 12/19/2014 58,473
Risser Eric Blasius VP, Business Development 11/24/2014 9,400
Risser Eric Blasius VP, Business Development 11/24/2014 277,500
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 11/21/2014 7,772
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 11/21/2014 295,542
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 11/17/2014 1,965
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 11/14/2014 21,818
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 11/14/2014 541,513
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 11/17/2014 47,966
Bonvini Ezio Senior VP, Research 11/14/2014 2,769
Risser Eric Blasius VP, Business Development 11/13/2014 9,400
Risser Eric Blasius VP, Business Development 11/12/2014 9,400
Risser Eric Blasius VP, Business Development 11/12/2014 345,000
Risser Eric Blasius VP, Business Development 11/13/2014 250,000
SARAN ATUL See remarks 10/28/2014 18,848
Bonvini Ezio Senior VP, Research 10/10/2014 284
Bonvini Ezio Senior VP, Research 10/08/2014 1,501
Bonvini Ezio Senior VP, Research 10/09/2014 1,891
Wigginton Jon Marc Sr V.P., Clinical 10/01/2014 23,500
Wigginton Jon Marc Sr V.P., Clinical 10/01/2014 102,400
Risser Eric Blasius VP, Business Development 09/02/2014 173,721
Wigginton Jon Marc Senior VP, Clinical Dev. 08/18/2014 23,500
Wigginton Jon Marc Senior VP, Clinical Dev. 08/18/2014 102,600
Risser Eric Blasius VP, Business Development 06/30/2014 7,520
Risser Eric Blasius VP, Business Development 06/30/2014 174,720
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 05/29/2014 7,772
Stein Kathryn E Senior VP, Prd Dev & Reg Aff 05/29/2014 216,184
HURWITZ EDWARD Director 02/18/2014 11,260,725
ORONSKY ARNOLD L Director 02/18/2014 7,300,000
Galbraith Kenneth Director 10/16/2013 750,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
06/30/2021
2.22%
2Q
12/31/2021
06/30/2020
21.06%
6Q
12/31/2021
12/31/2019
24.67%
8Q
12/31/2021
06/30/2019
26.91%
10Q
12/31/2021
03/31/2019
31.44%
11Q
12/31/2021
12/31/2018
46.47%
12Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
2.22%
2Q
06/30/2020
21.06%
6Q
12/31/2019
24.67%
8Q
06/30/2019
26.91%
10Q
03/31/2019
31.44%
11Q
12/31/2018
46.47%
12Q
Load More